|
|
|
|
Type 2 diabetes is not associated with an increased risk for VTE
MedWire News: Type 2 diabetes and associated complications are not independent risk factors for incident venous thromboembolism (VTE), report researchers in the journal Arteriosclerosis, Thrombosis and Vascular Biology.Diabetes has...
|
|
|
Arteriosclerosis Diagnostic Device
, THE DOSHISHA, MURATA MANUFACTURING CO., LTD.Arteriosclerosis Diagnostic Device.
|
|
|
Fenofibrate-induced HDL effect may be influenced by homocysteine increase
MedWire News: Results from the FIELD study show that patients with greater fenofibrate-mediated increases in homocysteine are likely to have smaller increases in high-density lipoprotein (HDL) cholesterol, perhaps explaining the variable...
|
|
|
VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patie
Related: Comprehensive Phase 2 Program Combines Histology, Biomarkers and Non-Invasive Imaging to Demonstrate Mechanism of Action and Positive Impact on Vascular Inflammation SAN FRANCISCO, May 14 /PRNewswire-FirstCall/ -- (Nasdaq: VIAP -...
|
|
|
VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDC
Related: Data Presented at American Heart Association ATVB Conference Shows Reduction in Non-Calcified Plaque Volume and Fewer New Plaque Lesions in Treated Patients WASHINGTON and SAN FRANCISCO, May 1 /PRNewswire-FirstCall/ -- (Nasdaq: VIAP...
|
|
|
VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDC
Data Presented at American Heart Association ATVB Conference Shows Reduction in Non-Calcified Plaque Volume and Fewer New Plaque Lesions in Treated Patients WASHINGTON and SAN FRANCISCO, May 1 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals,...
|
